Lv4
598 积分 2025-11-21 加入
Advancements in therapeutic strategies and drug development for inflammatory bowel diseases
1个月前
已完结
Lysosome-targeting chimeras enable targeted protein degradation
3个月前
已关闭
Elevated levels of TL1A are associated with disease activity in patients with systemic sclerosis
4个月前
已完结
Establishing a flow cytometry‐based tissue receptor occupancy assay for an anti‐oncostatin M receptor beta subunit therapeutic candidate in inflammatory bowel disease
4个月前
已完结
Differential therapeutic implications of the OSM-OSMR signaling pathway in cancer and inflammatory diseases
4个月前
已完结
Increased levels of the soluble oncostatin M receptor (sOSMR) and glycoprotein 130 (sgp130) in systemic sclerosis patients and associations with clinical parameters
5个月前
已完结
Soluble oncostatin M receptor (sOSMR): A potential biomarker in systemic sclerosis diagnosis
5个月前
已完结
Oncostatin M Induces a Pro-inflammatory Phenotype in Intestinal Subepithelial Myofibroblasts
6个月前
已完结
Mouse models of inflammatory bowel disease☆
7个月前
已完结
The emerging role of BLyS/APRIL in autoimmune diseases: Biological characteristics, functions, and therapeutic potential
7个月前
已完结
皖公网安备34019202002308
